资讯

Viktor Gyokeres’ summer transfer preference has been revealed amid interest from Arsenal, Man Utd and Saudi Arabia, according to reports. The Gunners look likely to fall short of their goals ...
peak positions on this chart also relate to midweek chart positions. Official Albums Chart Update data available on officialcharts.com goes back to October 2014.
THE WEEK'S MOST POPULAR CLASSICAL ALBUMS, BASED ON MULTIMETRIC CONSUMPTION, BLENDING TRADITIONAL ALBUM SALES, STREAMING-EQUIVALENT ALBUMS AND TRACK-EQUIVALENT ALBUMS, AS COMPILED BY LUMINATE.
THE WEEK'S MOST POPULAR JAZZ ALBUMS, BASED ON MULTIMETRIC CONSUMPTION, BLENDING TRADITIONAL ALBUM SALES, STREAMING-EQUIVALENT ALBUMS AND TRACK-EQUIVALENT ALBUMS, AS COMPILED BY LUMINATE.
Conversely, even some of the best albums of all time still have one or two songs that don't work out. With 12 albums, many of which are long, Metallica has its fair share of amazing, good ...
Sugababes 2025 UK and Ireland 2025 tour setlist in full ...
United's appointment of his former head coach, Ruben Amorim, has inevitably led to rumours regarding a reunion at Old Trafford, such is the Reds' need for a centre-forward. The Sweden ...
Viktor Gyokeres' preference between Arsenal and Man United has been revealed, according to reports. The Sporting Lisbon striker has become one of Europe's most sought after stars following a ...
Manchester United and Arsenal's hopes of signing Viktor Gyokeres have been dealt a blow as another club has entered the race to secure his signature in the summer transfer window. The Sporting ...
Here is your 2025 hard rock + metal album release calendar and all of this week's newest albums! Each week is loaded with new rock and metal releases and keeping track of it all can be pretty ...
Viktor Gyokeres has attracted interest from Manchester United, Arsenal and Liverpool – but one Premier League club is at the forefront of his mind. Gyokeres has been in incredible goalscoring ...
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents ...